Product Details for ANDA 218070
LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)
EQ 0.005MG BASE
Marketing Status: Prescription
EQ 0.025MG BASE
Marketing Status: Prescription
EQ 0.05MG BASE
Marketing Status: Prescription
EQ 0.005MG BASE
Marketing Status: Prescription
Active Ingredient: LIOTHYRONINE SODIUM
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.005MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 001
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information
LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.005MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 001
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 0.025MG BASE
Marketing Status: Prescription
Active Ingredient: LIOTHYRONINE SODIUM
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.025MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 002
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information
LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.025MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 002
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 0.05MG BASE
Marketing Status: Prescription
Active Ingredient: LIOTHYRONINE SODIUM
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.05MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 003
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: LIOTHYRONINE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.05MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A218070
Product Number: 003
Approval Date: Feb 6, 2024
Applicant Holder Full Name: BIOCON PHARMA INC
Marketing Status: Prescription
Patent and Exclusivity Information